Skip Nav Destination
Antibiotics and Chemotherapy
Neonatal Group B Streptococcal Infections
S.Karger AG
Volume
35
Status:
Available
ISBN electronic:
978-3-318-03210-9
ISBN print:
978-3-8055-3953-1
Discontinued Book Series:
Antibiotics and Chemotherapy
Published online:
2015
Published in print:
1985
Neonatal Group B Streptococcal Infections
Edited by: K.K. Christensen, P. Christensen, P. Ferrieri
https://doi.org/10.1159/isbn.978-3-318-03210-9
ISBN (print): 978-3-8055-3953-1
ISBN (electronic): 978-3-318-03210-9
Publisher: S.Karger AG
Published: 1985
Download citation file:
Digital Version
Pay-Per-View Access
$291.00
Print Version
Neonatal Group B Streptococcal Infections
$291.00
Table of Contents
-
1 - 9: GBS: The Childhood and Adolescent Years1ByH. C. DillonH. C. DillonThe University of Alabama in Birmingham, School of Medicine, Departments of Pediatrics and Microbiology, Birmingham, Ala., USASearch for other works by this author on:
-
10 - 16: Epidemiology of GBS in ManByB. F. AnthonyB. F. AnthonyDepartment of Pediatrics, UCLA School of Medicine, Harbor-UCLA Medical Center, Torrance, Calif., USASearch for other works by this author on:
-
17 - 27: The Incidence of GBS Disease in Neonates in Different CountriesByR. T. Mayon-WhiteR. T. Mayon-WhitePublic Health Laboratory, John Radcliffe Hospital, Oxford, EnglandSearch for other works by this author on:
-
28 - 39: GBS Colonisation in Mothers and BabiesByC. S. F. Easmon;C. S. F. EasmonDepartment of Medical Microbiology, Wright-Fleming Institute, St. Mary’s Hospital Medical School, London, EnglandSearch for other works by this author on:M. J. G. HastingsM. J. G. HastingsDepartment of Medical Microbiology, Wright-Fleming Institute, St. Mary’s Hospital Medical School, London, EnglandSearch for other works by this author on:
-
40 - 48: Epidemiological Aspects of Human/Animal Interrelationship in GBSByN. E. JensenN. E. JensenState Veterinary Serum Laboratory, Ringsted, DenmarkSearch for other works by this author on:
-
49 - 52: The Nomenclature of GBSByJ. Jelínková;J. JelínkováDepartment of Medical Microbiology, Postgraduate Medical and Pharmaceutical Institute and Centre for Reference and Research on Streptococci, Institute of Hygiene and Epidemiology, Prague, CSSRSearch for other works by this author on:J. MotlováJ. MotlováDepartment of Medical Microbiology, Postgraduate Medical and Pharmaceutical Institute and Centre for Reference and Research on Streptococci, Institute of Hygiene and Epidemiology, Prague, CSSRSearch for other works by this author on:
-
53 - 56: The Bacteriology of GBSByJ. HenrichsenJ. HenrichsenThe Streptococcus Department, Statens Seruminstitut, Copenhagen, DenmarkSearch for other works by this author on:
-
57 - 70: GBS Enzymes, Hemolysin, Toxins and Other Products1ByP. FerrieriP. FerrieriDepartments of Laboratory Medicine and Pathology and of Pediatrics, University of Minnesota Medical School, Minneapolis, Minn., USASearch for other works by this author on:
-
71 - 82: The Genetics of GBSByR. LüttickenR. LüttickenInstitute of Hygiene, University of Köln, Köln, FRGSearch for other works by this author on:
-
83 - 89: Antimicrobial Susceptibility of GBSByK. S. KimK. S. KimDepartment of Pediatrics, UCLA School of Medicine, Harbor-UCLA Medical Center, Torrance, Calif., USASearch for other works by this author on:
-
90 - 100: Cell Structure and Antigenic Composition of GBSByD. L. Kasper;D. L. KasperChanning Laboratory, Brigham and Women’s Hospital, and Division of Infectious Diseases, Beth Israel Hospital, Harvard Medical School, Boston, Mass., USA; Department of Pediatrics, Microbiology and Immunology, Baylor College of Medicine, Houston, Tex., USA; Division of Biological Sciences, National Research Council of Canada, Ottawa, Ontario, CanadaSearch for other works by this author on:C. J. Baker;C. J. BakerChanning Laboratory, Brigham and Women’s Hospital, and Division of Infectious Diseases, Beth Israel Hospital, Harvard Medical School, Boston, Mass., USA; Department of Pediatrics, Microbiology and Immunology, Baylor College of Medicine, Houston, Tex., USA; Division of Biological Sciences, National Research Council of Canada, Ottawa, Ontario, CanadaSearch for other works by this author on:H. J. JenningsH. J. JenningsChanning Laboratory, Brigham and Women’s Hospital, and Division of Infectious Diseases, Beth Israel Hospital, Harvard Medical School, Boston, Mass., USA; Department of Pediatrics, Microbiology and Immunology, Baylor College of Medicine, Houston, Tex., USA; Division of Biological Sciences, National Research Council of Canada, Ottawa, Ontario, CanadaSearch for other works by this author on:
-
101 - 113: The Ibc ProteinsByL. BevangerL. BevangerDepartment of Microbiology, Regional Hospital, Trondheim, NorwaySearch for other works by this author on:
-
114 - 118: The R-ProteinsByK. K. Christensen;K. K. ChristensenDepartments of Obstetrics and Gynecology, and Medical Microbiology, University Hospital, Lund, SwedenSearch for other works by this author on:P. ChristensenP. ChristensenDepartments of Obstetrics and Gynecology, and Medical Microbiology, University Hospital, Lund, SwedenSearch for other works by this author on:
-
119 - 127: Immunoelectron Microscopical Demonstration of the Cell Wall and Capsular Antigens of GBS1ByM. Wagner;M. WagnerResearch Center for Molecular Biology and Medicine, Central Institute of Microbiology and Experimental Therapy, Academy of Sciences of the GDR, Jena, GDRSearch for other works by this author on:B. WagnerB. WagnerResearch Center for Molecular Biology and Medicine, Central Institute of Microbiology and Experimental Therapy, Academy of Sciences of the GDR, Jena, GDRSearch for other works by this author on:
-
128 - 141: Pathogenic Mechanisms in Neonatal GBS InfectionByE. M. Ayoub;E. M. AyoubDepartment of Pediatrics, University of Florida, College of Medicine, Gainesville, Fla., USASearch for other works by this author on:H. SwingleH. SwingleDepartment of Pediatrics, University of Florida, College of Medicine, Gainesville, Fla., USASearch for other works by this author on:
-
142 - 156: Cellular and Humoral Aspects of Host Defense Mechanisms against GBS1ByS. P. Gotoff;S. P. GotoffDivision of Infectious Diseases, Department of Pediatrics, Michael Reese Hospital and Medical Center, University of Chicago Pritzker School of Medicine, Chicago, Ill., USASearch for other works by this author on:K. M. BoyerK. M. BoyerDivision of Infectious Diseases, Department of Pediatrics, Michael Reese Hospital and Medical Center, University of Chicago Pritzker School of Medicine, Chicago, Ill., USASearch for other works by this author on:
-
157 - 169: Methods of Assessment and Importance of Opsonic Activity for GBSByH. R. Hill;H. R. HillDepartments of Pathology and Pediatrics, University of Utah School of Medicine, Salt Lake City, Utah, USASearch for other works by this author on:A. O. Shigeoka;A. O. ShigeokaDepartments of Pathology and Pediatrics, University of Utah School of Medicine, Salt Lake City, Utah, USASearch for other works by this author on:N. S. Rote;N. S. RoteDepartments of Pathology and Pediatrics, University of Utah School of Medicine, Salt Lake City, Utah, USASearch for other works by this author on:C. D. Allred;C. D. AllredDepartments of Pathology and Pediatrics, University of Utah School of Medicine, Salt Lake City, Utah, USASearch for other works by this author on:V. G. HemmingV. G. HemmingDepartments of Pathology and Pediatrics, University of Utah School of Medicine, Salt Lake City, Utah, USASearch for other works by this author on:
-
170 - 189: The Role of Complement in Opsonization of GBS1ByM. S. Edwards;M. S. EdwardsSection of Infectious Diseases of the Departments of Pediatrics, Microbiology and Immunology, Baylor College of Medicine, Houston, Tex.; Division of Infectious Diseases, Beth Israel Hospital and Channing Laboratory, and Department of Rheumatology and Immunology, Brigham and Women’s Hospital, Harvard Medical School, Boston, Mass., USASearch for other works by this author on:D. L. Kasper;D. L. KasperSection of Infectious Diseases of the Departments of Pediatrics, Microbiology and Immunology, Baylor College of Medicine, Houston, Tex.; Division of Infectious Diseases, Beth Israel Hospital and Channing Laboratory, and Department of Rheumatology and Immunology, Brigham and Women’s Hospital, Harvard Medical School, Boston, Mass., USASearch for other works by this author on:A. Nicholson- Weller;A. Nicholson- WellerSection of Infectious Diseases of the Departments of Pediatrics, Microbiology and Immunology, Baylor College of Medicine, Houston, Tex.; Division of Infectious Diseases, Beth Israel Hospital and Channing Laboratory, and Department of Rheumatology and Immunology, Brigham and Women’s Hospital, Harvard Medical School, Boston, Mass., USASearch for other works by this author on:C. J. BakerC. J. BakerSection of Infectious Diseases of the Departments of Pediatrics, Microbiology and Immunology, Baylor College of Medicine, Houston, Tex.; Division of Infectious Diseases, Beth Israel Hospital and Channing Laboratory, and Department of Rheumatology and Immunology, Brigham and Women’s Hospital, Harvard Medical School, Boston, Mass., USASearch for other works by this author on:
-
190 - 193: Immunological Characterization of Mothers of Infants with Neonatal GBS Infection: Definition of a Risk GroupByK. K. Christensen;K. K. ChristensenDepartments of Obstetrics and Gynecology and Medical Microbiology, University Hospital, Lund, SwedenSearch for other works by this author on:P. ChristensenP. ChristensenDepartments of Obstetrics and Gynecology and Medical Microbiology, University Hospital, Lund, SwedenSearch for other works by this author on:
-
194 - 200: Matemal Humoral Immunity and Neonatal GBS Infection: Studies in a Primate ModelByV. G. Hemming;V. G. HemmingDepartments of Pediatrics and Pathology, Uniformed Services University of the Health Sciences, Infectious Disease Branch, National Institute of Neurological and Communicative Disorders and Stroke, National Institutes of Health, Bethesda, Md., USASearch for other works by this author on:W. T. London;W. T. LondonDepartments of Pediatrics and Pathology, Uniformed Services University of the Health Sciences, Infectious Disease Branch, National Institute of Neurological and Communicative Disorders and Stroke, National Institutes of Health, Bethesda, Md., USASearch for other works by this author on:B. L. Curfman;B. L. CurfmanDepartments of Pediatrics and Pathology, Uniformed Services University of the Health Sciences, Infectious Disease Branch, National Institute of Neurological and Communicative Disorders and Stroke, National Institutes of Health, Bethesda, Md., USASearch for other works by this author on:D. F. Patrick;D. F. PatrickDepartments of Pediatrics and Pathology, Uniformed Services University of the Health Sciences, Infectious Disease Branch, National Institute of Neurological and Communicative Disorders and Stroke, National Institutes of Health, Bethesda, Md., USASearch for other works by this author on:G. W. FischerG. W. FischerDepartments of Pediatrics and Pathology, Uniformed Services University of the Health Sciences, Infectious Disease Branch, National Institute of Neurological and Communicative Disorders and Stroke, National Institutes of Health, Bethesda, Md., USASearch for other works by this author on:
-
201 - 210: Phagocytosis and Killing of GBS in an Experimental Animal ModelByS. E. Holm;S. E. HolmInstitute of Clinical Bacteriology, University of Umeå, Umeå, Sweden; and Research Center for Molecular Biology and Medicine, Central Institute of Microbiology and Experimental Therapy, Academy of Sciences of the GDR, Jena, GDRSearch for other works by this author on:A. M. Bergholm;A. M. BergholmInstitute of Clinical Bacteriology, University of Umeå, Umeå, Sweden; and Research Center for Molecular Biology and Medicine, Central Institute of Microbiology and Experimental Therapy, Academy of Sciences of the GDR, Jena, GDRSearch for other works by this author on:B. Wagner;B. WagnerInstitute of Clinical Bacteriology, University of Umeå, Umeå, Sweden; and Research Center for Molecular Biology and Medicine, Central Institute of Microbiology and Experimental Therapy, Academy of Sciences of the GDR, Jena, GDRSearch for other works by this author on:M. WagnerM. WagnerInstitute of Clinical Bacteriology, University of Umeå, Umeå, Sweden; and Research Center for Molecular Biology and Medicine, Central Institute of Microbiology and Experimental Therapy, Academy of Sciences of the GDR, Jena, GDRSearch for other works by this author on:
-
211 - 224: GBS Infections in the Newborn Infant: Diagnosis and Treatment1ByP. FerrieriP. FerrieriDepartments of Laboratory Medicine and Pathology and of Pediatrics, University of Minnesota Medical School, Minneapolis, Minn., USASearch for other works by this author on:
-
225 - 236: GBS Infections in Mothers and Their Infants1ByB. M. Gray;B. M. GrayThe University of Alabama in Birmingham, School of Medicine, Departments of Pediatrics and Microbiology, Birmingham, Ala., USASearch for other works by this author on:H. C. DillonH. C. DillonThe University of Alabama in Birmingham, School of Medicine, Departments of Pediatrics and Microbiology, Birmingham, Ala., USASearch for other works by this author on:
-
237 - 246: Gammaglobulin as a Measure for Treating Neonatal GBS InfectionsByG. W. FischerG. W. FischerDepartment of Pediatrics, Uniformed Services University of the Health Sciences, School of Medicine, Bethesda, Md., USASearch for other works by this author on:
-
247 - 253: Intravenous Administration of Human IgG to Newborn Infants: Changes in Serum Antibody Levels to GBSByK. K. Christensen;K. K. ChristensenaDepartments of Obstetrics and Gynecology andSearch for other works by this author on:P. Christensen;P. ChristensenbMedical Microbiology, University Hospital, Lund, Sweden andSearch for other works by this author on:R. A. SegerR. A. SegercDepartment of Pediatrics, Division of Haematology/Immunology and Neonatology, University of Zürich, SwitzerlandSearch for other works by this author on:
-
254 - 266: Monoclonal Antibody Preparations for Immunotherapy of Experimental GBS InfectionByA. O. Shigeoka;A. O. ShigeokaaDepartments of Pediatrics,Search for other works by this author on:N. S. Rote;N. S. RotebObstetrics and Gynecology and Pathology, University of Utah, School of Medicine, Salt Lake City, Utah;Search for other works by this author on:D. G. Pritchard;D. G. PritchardcDepartment of Microbiology, University of Alabama at Birmingham, Ala.;Search for other works by this author on:J. I. Santos;J. I. SantosdBoston University School of Medicine, Boston, Mass., USASearch for other works by this author on:H. R. HillH. R. HillaDepartments of Pediatrics,Search for other works by this author on:
-
267 - 280: Strategies for Chemoprophylaxis of GBS Early-Onset Infections1ByK. M. Boyer;K. M. BoyerDivision of Infectious Diseases, Department of Pediatrics, Michael Reese Hospital and Medical Center, University of Chicago Pritzker School of Medicine, Chicago, Ill., USASearch for other works by this author on:S. P. GotoffS. P. GotoffDivision of Infectious Diseases, Department of Pediatrics, Michael Reese Hospital and Medical Center, University of Chicago Pritzker School of Medicine, Chicago, Ill., USASearch for other works by this author on:
-
281 - 290: Vaccination as a Measure for Prevention of Neonatal GBS InfectionByCarol J. Baker;Carol J. BakerSection of lnfectious Diseases, Departments of Pediatrics, Microbiology and Immunology, Baylor College of Medicine, Houston, Tex., and the Division of Infectious Diseases, Beth Israel Hospital and Channing Laboratory, Harvard Medical School, Boston, Mass., USASearch for other works by this author on:Dennis L. KasperDennis L. KasperSection of lnfectious Diseases, Departments of Pediatrics, Microbiology and Immunology, Baylor College of Medicine, Houston, Tex., and the Division of Infectious Diseases, Beth Israel Hospital and Channing Laboratory, Harvard Medical School, Boston, Mass., USASearch for other works by this author on:
-
291 - 295: The Soluble Antigens of GBS as Human VaccinesByR. M. Swenson;R. M. SwensonDepartment of Microbiology and Immunology and Department of Medicine, Temple University School of Medicine, Philadelphia, Pa., USASearch for other works by this author on:T. K. Eisenstein;T. K. EisensteinDepartment of Microbiology and Immunology and Department of Medicine, Temple University School of Medicine, Philadelphia, Pa., USASearch for other works by this author on:G. D. ShockmanG. D. ShockmanDepartment of Microbiology and Immunology and Department of Medicine, Temple University School of Medicine, Philadelphia, Pa., USASearch for other works by this author on:
-
296 - 302: Chlorhexidine for Prevention of Neonatal Colonization with GBS1ByK. K. Christensen;K. K. ChristensenDepartment of Obstetrics and Gynecology and Medical Microbiology, University Hospital, Lund, SwedenSearch for other works by this author on:P. ChristensenP. ChristensenDepartment of Obstetrics and Gynecology and Medical Microbiology, University Hospital, Lund, SwedenSearch for other works by this author on:
-
303 - 304: Nomenclature of GBS Antigens1ByJ. HenrichsenJ. HenrichsenThe Streptococcus Department, Statens Seruminstitut, Copenhagen, DenmarkSearch for other works by this author on:
